AIP, a Protein Mutated in Familial Acromegaly, Plays a Role in the Regulation of Cell Proliferation and Shows Cell-Type Specific Subcellular Localisation
Main Authors: | Leontiou, C, Gueorguiev, M, Hassan, S, van der Spuy, J, Lolli, F, Stolbrink, M, Christian, H, Wray, J, Bishop-Bailey, D, Berney, D, Frohman, L, Chapple, J, Grossman, AB, Korbonits, M |
---|---|
Format: | Conference item |
Published: |
2009
|
Similar Items
-
Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
by: Chahal, H, et al.
Published: (2011) -
AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
by: Chahal, H, et al.
Published: (2010) -
Increased population risk of AIP-related acromegaly and gigantism in Ireland.
by: Radian, S, et al.
Published: (2016) -
Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
by: Chahal, H, et al.
Published: (2012) -
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
by: Igreja, S, et al.
Published: (2010)